TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/23 12:14 | 8/23/23 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P | 33 | 0.3300 | 0 | 100 | 1 | 14,768 | D | ||||||||||||||
8/23/23 09:24 | 8/22/23 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P | 64 | 0.3220 | 0 | 200 | 1 | 14,668 | D | ||||||||||||||
6/2/22 09:46 | 6/1/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P.a | 58 | 0.5800 | 0 | 100 | 1 | 14,868 | D | ||||||||||||||
6/2/22 08:55 | 6/1/22 | NRXP | Nrx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Javitt Jonathan C | DE | DOT | Chief Sc | P | 5,800 | 58.00 | 0 | 100 | 1 | 14,868 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |